Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 52Carcinoma, Renal Cell 47Neoplasm Metastasis 24Neoplasms 18Kidney Neoplasms 18Neuroendocrine Tumors 17Carcinoma, Non-Small-Cell Lung 13Tuberous Sclerosis 12Stomach Neoplasms 12Lymphoma, Mantle-Cell 12Lymphoma, Large B-Cell, Diffuse 11Recurrence 10Prostatic Neoplasms 10Lymphoma 10Hodgkin Disease 10Glioblastoma 10Colorectal Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Brain Neoplasms 9Lymphoma, Follicular 8Lung Neoplasms 8Leukemia, Lymphocytic, Chronic, B-Cell 8Carcinoma 8Waldenstrom Macroglobulinemia 7Triple Negative Breast Neoplasms 7Sarcoma 7Multiple Myeloma 7Lymphoma, B-Cell, Marginal Zone 7Glioma 7Central Nervous System Neoplasms 7

Interventions

Paclitaxel 5Etoposide 4Oxaliplatin 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Gemcitabine 3Cyclophosphamide 3Cisplatin 3Carboplatin 3ribociclib 2fludarabine 2etoposide phosphate 2Stem Cell Transplantation 2Sirolimus 2Melphalan 2Filgrastim 2Everolimus 2Busulfan 2130-nm albumin-bound paclitaxel 2trametinib 1tozuleristide 1sonidegib 1ripretinib 1pralsetinib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1pazopanib 1olaparib 1interferon gamma-1b 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms, Germ Cell and Embryonal × Everolimus × Clear all
NCT01466231 2016-01-12

Everolimus in Refractory Testicular Germ Cell Cancer

National Cancer Institute, Slovakia

Phase 2 Completed
15 enrolled

Neoplasms, Germ Cell and Embryonal

NCT01242631 2015-02-25

RADIT

Hannover Medical School

Phase 2 Completed
25 enrolled
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡